ArticleSurgery2025
Association between frailty progression and clinical outcomes in patients with diabetic foot ulcers.
Article in Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Associations of activities of daily living and their trajectories with the risk of diabetes-related lower-limb amputation: evidence from the HRS and ELSA longitudinal cohorts.Frontiers in endocrinology · 2026Article
- Establishment and evaluation of a novel tool based on inflammation-nutrition derived biomarkers for early diagnosis of diabetic foot ulcers.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundFrailty is a critical determinant of adverse outcomes in patients with diabetic foot ulcers, yet its progression remains poorly understood. This study investigated frailty progression in patients with diabetic foot ulcers to inform targeted limb preservation strategies.
methodsThis prospective study included 178 patients with diabetic foot ulcers diagnosed within 6 months and followed for 12 months. Baseline frailty was assessed using the Clinical Frailty Scale, with patients categorized as frail or nonfrail. Frailty progression and diabetic foot ulcer-related outcomes were monitored, and logistic regression was used to identify factors associated with frailty development.
resultsThe mean age was 55.4 years; 67% of patients were female, 35% had peripheral artery disease, and 13% had end-stage kidney disease. At baseline, 42% (n = 75) were frail and 58% (n = 103) were nonfrail. All patients deemed initially frail remained frail at 12 months, whereas 25% (n = 26) of patients who were deemed nonfrail developed frailty. In multivariable logistic regression, baseline frailty was significantly associated with peripheral artery disease, myocardial infarction, and non-Hispanic ethnicity (all P < .05). In univariable logistic regression, frailty development among patients who were initially deemed nonfrail was associated with peripheral artery disease (odds ratio, 4.64; 95% confidence interval, 1.74-12.70), nonhealing ulcers (odds ratio, 2.96; 95% confidence interval, 1.20-7.63), revascularization procedures (odds ratio, 9.09; 95% confidence interval, 2.30-45.34), and diabetic foot ulcer-related hospitalizations (odds ratio, 1.96; 95% confidence interval, 1.32-3.03).
conclusionFrailty persisted among patients deemed initially frail, whereas 25% of patients who were initially deemed nonfrail developed frailty over 12 months. Future studies are needed to evaluate the role of proactive frailty screening and targeted management of risk factors to mitigate adverse outcomes among patients with diabetic foot ulcers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.